Theodore R Schroeder Insider Trading $NBRV Nabriva Therapeutics plc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Theodore R Schroeder.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Theodore R Schroeder. Theodore R Schroeder is Director in COLLEGIUM PHARMACEUTICAL, INC ($COLL) and President, CEO in CADENCE PHARMACEUTICALS INC ($CADX) and Director in HYPERION THERAPEUTICS INC ($HPTX) and Director in Otonomy, Inc. ($OTIC) and in Cidara Therapeutics, Inc. ($CDTX) and Director in Cidara Therapeutics, Inc. ($CDTX) and Chief Executive Officer in Nabriva Therapeutics plc ($NBRV) and Chief Executive Officer) in Nabriva Therapeutics plc ($NBRV).
Theodore R Schroeder in Nabriva Therapeutics plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Theodore R Schroeder: Chief Executive Officer)
Holdings: 178,203 shares
Current Value: $1,441,662
Latest Transaction: May 10 2021
$NBRV Market Capitalization: $180.88M
$NBRV Previous Close: $8.09
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Theodore R Schroeder in Nabriva Therapeutics plc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CADX, CDTX, COLL, HPTX, NBRV, OTIC
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.49 | 225 | 335 | 178,203 | 178.4 K to 178.2 K (-0.13 %) |
| May 04 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.78 | 107 | 190 | 178,428 | 178.5 K to 178.4 K (-0.06 %) |
| Apr 08 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.73 | 225 | 389 | 178,535 | 178.8 K to 178.5 K (-0.13 %) |
| Apr 08 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.73 | 225 | 389 | 178,535 | 178.8 K to 178.5 K (-0.13 %) |
| Apr 08 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.79 | 225 | 403 | 178,760 | 179 K to 178.8 K (-0.13 %) |
| Apr 08 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.79 | 225 | 403 | 178,760 | 179 K to 178.8 K (-0.13 %) |
| Apr 08 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 2.90 | 2,695 | 7,816 | 178,985 | 181.7 K to 179 K (-1.48 %) |
| Apr 08 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 2.90 | 2,695 | 7,816 | 178,985 | 181.7 K to 179 K (-1.48 %) |
| Apr 02 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.66 | 107 | 178 | 181,680 | 181.8 K to 181.7 K (-0.06 %) |
| Feb 02 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 2.62 | 125 | 328 | 181,893 | 182 K to 181.9 K (-0.07 %) |
| Feb 02 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Grant | A | 0.00 | 117,500 | 0 | 182,018 | 64.5 K to 182 K (+182.12 %) |
| Oct 01 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 0.53 | 1,211 | 645 | 648,818 | 650 K to 648.8 K (-0.19 %) |
| Sep 02 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 0.62 | 1,211 | 750 | 650,029 | 651.2 K to 650 K (-0.19 %) |
| Aug 04 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 0.76 | 1,211 | 920 | 651,240 | 652.5 K to 651.2 K (-0.19 %) |
| Jul 02 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 0.67 | 1,211 | 817 | 652,451 | 653.7 K to 652.5 K (-0.19 %) |
| Jun 03 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.14 | 1,211 | 1,381 | 653,662 | 654.9 K to 653.7 K (-0.18 %) |
| May 04 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 0.55 | 1,211 | 664 | 648,686 | 649.9 K to 648.7 K (-0.19 %) |
| Apr 02 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 0.58 | 1,211 | 696 | 649,897 | 651.1 K to 649.9 K (-0.19 %) |
| Mar 03 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.35 | 1,211 | 1,635 | 651,108 | 652.3 K to 651.1 K (-0.19 %) |
| Feb 10 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Option Exercise | A | 1.35 | 687,500 | 928,125 | 687,500 | |
| Feb 10 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Grant | A | 0.00 | 343,800 | 0 | 646,560 | 302.8 K to 646.6 K (+113.56 %) |
| Feb 04 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.35 | 16,276 | 21,973 | 302,760 | 319 K to 302.8 K (-5.10 %) |
| Aug 28 2019 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Buy | P | 1.79 | 50,000 | 89,500 | 117,489 | 67.5 K to 117.5 K (+74.09 %) |
| Jul 25 2019 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Grant | A | 0.00 | 6,748 | 0 | 67,489 | 60.7 K to 67.5 K (+11.11 %) |
| Feb 04 2019 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Option Exercise | A | 0.00 | 163,250 | 0 | 163,250 | |
| Feb 04 2019 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Option Exercise | A | 0.00 | 429,800 | 0 | 429,800 | |
| Jul 27 2018 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
| Jul 27 2018 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Option Exercise | A | 0.00 | 850,000 | 0 | 850,000 |
Page: 1